ETF PROAI
ETF PRO AIOctober 3, 2026

BBH VanEck Biotech ETF

Fund tearsheet · data as of the latest session · October 3, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$488Mfund assets
+25.5%return, YTD
+37.0%return, 1 year
+$3Mnet flow, 1 month
−$23Mnet flow, 1 year
21.5%realized volatility, 1y
-10.5%worst drawdown, 1y
Top ten holdings
1AMGN AMGEN15.79%
2GILD GILEAD SCIENCES13.19%
3VRTX VERTEX PHARMACEUTICALS8.22%
4REGN REGENERON PHARMACEUTICALS6.50%
5MRNA MODERNA6.07%
6NTRA NATERA5.34%
7ARGX ARGENX SE4.59%
8IQV IQVIA HOLDINGS4.47%
9RVMD REVOLUTION MEDICINES4.22%
10ILMN ILLUMINA4.05%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.